Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Roger Stupp MD
Roger Stupp MD Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Barbara Burtness MD
Barbara Burtness MD Advisory Board
See All Experts
story of the week
Published in Oncology

Journal Scan / Research · January 10, 2024

Mesenchymal Stem Cells for Prophylaxis of Chronic GVHD After Haploidentical HSCT

JAMA Oncology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Navneet Majhail MD, MS, FASTCT

JAMA Oncology
Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant: An Open-Label Randomized Clinical Trial
JAMA Oncol 2023 Dec 28;[EPub Ahead of Print], R Huang, T Chen, S Wang, J Wang, Y Su, J Liu, Y Zhang, X Ma, Q Wen, P Kong, C Zhang, L Gao, JF Zhong, L Gao, X Zhang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated